Skip to content
The Policy VaultThe Policy Vault

Xalkori 20 mg pellets — Cigna

anaplastic large cell lymphoma

Initial criteria

  • Patient has anaplastic large cell lymphoma AND requires a dose reduction to 80 mg twice daily OR
  • Patient age < 18 years AND has inflammatory myofibroblastic tumor AND requires a dose reduction to 80 mg twice daily

Approval duration

1 year